2959

LIVE CASE TRANSMISSION AND WHAT'S NEW (10月26日)

  • Hans-Reiner Figulla : TAVR for aortic regurgitation
  • Vaikom Mahedevan : Non-invasive imaging pathways for coronary artery disease
  • Liwen Liu : A new technique for transthoracic treatment of HOCM
  • Maxim Itkin : Lymphatic interventions for complications of congenital heart diseases
  • Frank Ing : Recanalization of chronically occluded veins
  • James Thompson : Live transmission from Inova Heart and Vascular Institute, Falls Church, Virginia

MITRAL VALVE REPAIR AND REPLACEMENT (10月26日)

  • Vaikom Mahadevan : Mitral valve in MAC: patient selection and how to do it
  • Jacob Mishell : Mitral edge-to-edge repair for FMR – Update on clinical trials
  • Marvin Eng : Initial experience with PASCAL
  • Mark Reisman : Initial experience with the new Mitraclip
  • Eberhard Grube : Update on transcatheter mitral annuloplasty techniques
  • Brian Whisenant : Cardioband
  • Horst Sievert : Deep dive into first and only blinded randomized trial in mitral valve repair
  • Danny Dvir : Mitral valve in valve and valve in ring: my 10 most important tips and tricks
  • Eberhard Grube : Early results with dedicated mitral valves

TAVR (10月26日)

  • Stefan Bertog : Live transmission from Minneapolis Veterans Affairs Medical Center,Minneapolis, USA
  • Rajendra Makkar : TAVR for younger and low risk patients: what are the concerns?
  • Eberhard Grube : Pro
  • Brian Whisenant : Con
  • Suneet Mittal : When should RV pacing be performed for TAVR?
  • Rahul Sharma : Centera Valve
  • Tarun Chakravarty : New valves-New Lotus
  • Eberhard Grube : Other new valves
  • Rajendra Makkar : Best strategy to prevent leaflet thrombosis
  • Eberhard Grube : Minimalist approach – Pro and con
  • Kirsten Tolstrup : Is there a role for TEE in TAVR
  • Horst Sievert : Strategy for bicuspid aortic valve diseases - Experiences from China
  • Horst Sievert : The PerQSeal closure device

Live Only (10月26日)

  • Rajendra Makkar : Cedars Sinai Medical Center, Los Angeles, USA
  • Stefan Bertog : Minneapolis Veterans Affairs Medical Center, Minneapolis, USA
  • James Thompson : Inova Heart and Vascular Institute, Virginia, USA

STROKE DETECTION AND PREVENTION OPTIONS (10月27日)

  • Wade Smith : The diagnosis of ischemic and cryptogenic stroke
  • Mintu Turakhia : Prevalence of ICH and role of OAC in preventing ischemic stroke
  • Michel Barakat : Role of atrial fibrosis in stroke and AF
  • Gregory Marcus : AF Monitoring devices – What information do they provide for strokeprevention
  • James Cox : Can sinus rhythm be obtained in persistent and longstanding persistent AF?Implications for stroke prevention
  • David Wilber : Implication of AF ablation studies? (Crystal AF, aMAZE, Cabanan, East)

INTERVENTIONS FOR STROKE PREVENTION: ARE THE DATA CONVINCING? (10月27日)

  • Maurice Buchbinder : Rationale for LAA occlusion in the prevention of stroke – Efficacy, safety and cost benefits
  • Jonathan Hsu : Should an epicardial LAA approach be considered in patients with contraindications to OAC therapy?
  • John Carroll : PFO closure: the long journey from experimental medicine to a class IArecommendation
  • James Freeman : Should LAA closure be performed routinely during surgery? Impact on stroke
  • Guy Shinar : A new minimally invasive concept for permanent stroke prevention

CONTROVERSIES IN STROKE PREVENTION AND ARRHYTHMIAS (10月27日)

  • Horst Sievert : Recorded case: PFO closure with Amplatzer PFO occluder - step by step
  • David Wilber : How do you prevent stroke in the anticoagulation contraindicated patient?
  • David Holmes : How serious is device related thrombus? Real life perspective.
  • James Cox : LAA closure and leaks: What is the significance?
  • Edward Gerstenfeld : Should AF ablation be used to prevent CHF?
  • Byron Lee : Vest predicts: what did we learn?
  • Mark La Meir : Surgical Treatment of inappropriate sinus tachycardia and POTTS syndrome
  • Jayanthi Koneru : His Bundle pacing instead of CRT?

KEYNOTE LECTURES (10月27日)

  • Yuval Binur : CV innovations - where are we heading to in the changing world
  • Peter Fitzgerald : What could be the next really ground breaking innovations in cardiovascularmedicine?

WHY CLOSE THE LAA – CONVENTIONAL AND EXPANDED INDICATIONS (10月27日)

  • Vijay Swarup : Live transmission from Arizona Heart Rhythm Center, Phoenix, USA
  • Krzysztof Bartus : LAA closure with LARIAT: influence on hormonal regulation and coagulation
  • David Holmes : Real World Experience for LAA closure
  • Michael Hoskins : Does LAA closure for the treatment of AF make sense?
  • Jonathan Hsu : Is there a role for LAA closure devices and low dose OAC therapy?
  • Jacqueline Saw : LAA US trials: Ongoing and future trials
  • Randall Lee : Case presentations of different LAA cases – Determination of the optimal LAA closure device

PFO CLOSURE (10月27日)

  • Karl Meisel : A deep dive into the Amplatzer PFO trials
  • Matthew Price : REDUCE deep dive
  • Debate: size of PFO and right to left shunt ….
  • John Rhodes, Jr. : matters
  • Matthew Price : doesn’t matter
  • Matthew Price : Atrial fibrillation after PFO closure: how frequent? How to deal with it? What isthe prognosis?
  • John Rhodes, Jr. : CARDIOFORM vs. Helex closure rate
  • Keshav Nayak : Should we close PFOs in divers before something happens?

SHARK TANK (non CME accredited) (10月27日)

CLOSING REMARKS (10月27日)